Table 4.

Proteinuria and M-type phospholipase A2 receptor autoantibody levels at the time of reaching the study end point or the end of follow-up

At End of Follow-UpAll PatientsTertile 1 (Low)Tertile 2 (Medium)Tertile 3 (High)P Value
Tertile 1 Versus 2Tertile 1 Versus 3Tertile 2 Versus 3
Proteinuria (g/24 h)2.1 (0.6–6.0)1.4 (0.3–4.0)2.5 (0.8–5.4)3.7 (0.7–9.6)0.140.030.24
PLA2R-Ab level (units/ml)12 (2–76)5 (2–36)18 (2–66)48 (3–166)0.380.030.12
  • Proteinuria and PLA2R-Ab levels are measured at the time when the patients reached the study end point or the end of the follow-up (for patients who did not reach the study end point). Data on proteinuria were available for 35 patients in tertile 1, 31 patients in tertile 2, and 30 patients in tertile 3. Data on PLA2R-Ab levels were available for 36 patients in tertile 1, 37 patients in tertile 2, and 34 patients in tertile 3. Data are presented as medians and interquartile ranges.